Literature DB >> 23718644

Reasons for exclusion of 6820 umbilical cord blood donations in a public cord blood bank.

Tso-Fu Wang1, Shu-Hui Wen, Kuo-Liang Yang, Shang-Hsien Yang, Yun-Fan Yang, Chu-Yu Chang, Yi-Feng Wu, Shu-Huey Chen.   

Abstract

BACKGROUND: To provide information for umbilical cord blood (UCB) banks to adopt optimal collection strategies and to make UCB banks operate efficiently, we investigated the reasons for exclusion of UCB units in a 3-year recruitment period. STUDY DESIGN AND METHODS: We analyzed records of the reasons for exclusion of the potential UCB donation from 2004 to 2006 in the Tzu-Chi Cord Blood Bank and compared the results over 3 years. We grouped these reasons for exclusion into five phases, before collection, during delivery, before processing, during processing, and after freezing according to the time sequence and analyzed the reasons at each phase.
RESULTS: Between 2004 and 2006, there were 10,685 deliveries with the intention of UCB donation. In total, 41.2% of the UCB units were considered eligible for transplantation. The exclusion rates were 93.1, 48.4, and 54.1% in 2004, 2005, and 2006, respectively. We excluded 612 donations from women before their child birth, 133 UCB units during delivery, 80 units before processing, 5010 units during processing, and 421 units after freezing. There were 24 UCB units with unknown reasons of ineligibility. Low UCB weight and low cell count were the first two leading causes of exclusion (48.6 and 30.9%). The prevalence of artificial errors, holiday or transportation problem, low weight, and infant problems decreased year after year.
CONCLUSION: The exclusion rate was high at the beginning of our study as in previous studies. Understanding the reasons for UCB exclusion may help to improve the efficiency of UCB banking programs in the future.
© 2013 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2013        PMID: 23718644     DOI: 10.1111/trf.12269

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Intrabone transplantation of CD34+ cells with optimized delivery does not enhance engraftment in a rhesus macaque model.

Authors:  Kate Stringaris; Robert F Hoyt; Jan K Davidson-Moncada; Jeremy M Pantin; John F Tisdale; Naoya Uchida; Lydia N Raines; Robert Reger; Noriko Sato; Cynthia E Dunbar; Timothy J Hunt; Randall R Clevenger; Allen Krouse; Mark E Metzger; Aylin C Bonifacino; William Telford; Peter L Choyke; Theresa Engels; Robert E Donahue; Richard W Childs
Journal:  Blood Adv       Date:  2020-12-22

2.  Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille Cord Blood Bank.

Authors:  C Bordoni; J Magalon; C Gilbertas; M Gamerre; P Le Coz; M Berthomieu; C Chabannon; J Di Cristofaro; C Picard
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

3.  Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo.

Authors:  Hao Daniel Lin; Chui-Yee Fong; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Res Ther       Date:  2020-12-09       Impact factor: 6.832

4.  Nov/CCN3 Enhances Cord Blood Engraftment by Rapidly Recruiting Latent Human Stem Cell Activity.

Authors:  Rajeev Gupta; Virginia Turati; Duncan Brian; Craig Thrussel; Barry Wilbourn; Gillian May; Tariq Enver
Journal:  Cell Stem Cell       Date:  2020-03-19       Impact factor: 24.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.